Improved Patient Care with Ultrasound

Iatrogenic Pneumothorax Complications: Zero

The prestigious Memorial Hermann Healthcare System achieved zero iatrogenic pneumothorax complications for one year. Learn how they achieved this feat in several of its hospitals and eight of its community hospital emergency departments. Learn how your hospital can also achieve zero iatrogenic pneumothorax complications.

Improving Quality of Care and Patient Safety While Saving Money

Multiple studies have demonstrated that ultrasound guidance improves the success rate and safety of invasive procedures including central venous lines, paracentesis and thoracentesis. Avoiding complications is not only is good for patient care, it reduces the overall cost of care for hospitals. A recent study conducted by United BioSource Corporation (UBC) demonstrated this cost reduction. Two recent studies, presented at the 2011 National Patient Safety Foundation (NPSF) Annual Meeting, found significant economic savings when ultrasound guidance was used as part of the care pathway. The largest studies of their type, they examined both paracentesis and thoracentesis and found fewer complications in the ultrasound guided group as well as substantial cost savings. As an example, a single iatrogenic pneumothorax increased hospital costs by more than $2,700 and a single bleeding complication during a paracentesis increased hospital costs over $20,000. Furthermore, both groups with complications had significantly longer hospital length of stays. Read more below on the economic and safety benefits of patients receiving ultrasound guidance for their thoracentesis or paracentesis.

Paracentesis

For the 69,859 patients who underwent a paracentesis, suffering a bleeding complication boosted hospital costs to nearly $30,000, about triple the cost for patients without a complication ($9,476) and length of hospital stay almost doubled, from a mean of 5.2 days for a patient without a bleeding complication to a mean of 9.5 days for a patient with one. Read the paracentesis abstract

Thoracentesis

For the 61,261 patients included in the analysis who underwent a thoracentesis, ultrasound guidance reduced the incidence of a pneumothorax by 19%. This complication increased a patient's hospital cost to $13,784, compared to $11,032 for a patient who didn't suffer a pneumothorax. In addition, the mean length of hospital stay was 7.9 days for a patient with a pneumothorax, versus 6.5 days for a patient without it. Read the thoracentesis abstract

The studies, "Clinical and Economic Advantage of Ultrasound Guidance Among Patients Undergoing Paracentesis" and "Clinical and Economic Advantage of Ultrasound Guidance Among Patients Undergoing Thoracentesis" were completed for SonoSite by the United BioSource Corporation (UBC), a global scientific and medical affairs organization. Researchers from the UBC Center for Epidemiology and Database Analytics used the national Premier Perspective® automated hospitalization claims database to access thousands of patients' records in over 600 hospitals from across the country.

The Recommendations are Clear

Based on this robust evidence, multiple government organizations and societies advocate ultrasound guidance:

AHRQ – Agency for Healthcare Research and Quality

NICE – National Institute for Health and Clinical Excellence

CDC – Centers for Disease Control and Prevention

American College of Surgeons

American College of Emergency Physicians

American College of Chest Physicians

American Board of Internal Medicine

Association for Vascular Access

Let Us Help You Lessen Line Placement Complications at Your Hospital

SonoSite is committed to quality care and partners with hospitals to achieve that goal. To facilitate the process, SonoSite has created the Central Line Management Program. This evidence-based program includes AHRQ, CDC and IHI recommendations and addresses both mechanical and infective complications of central venous catheters, allowing you to decrease:

SonoSite is committed to quality care and partners with hospitals to achieve that goal. To facilitate the process, SonoSite has created the Central Line Management Program. This evidence-based program includes AHRQ, CDC and IHI recommendations and addresses both mechanical and infective complications of central venous catheters, allowing you to decrease: